Resurfacing Marico's August 2025 Q1 FY26 report: revenue rose 23%, profit up 8.2% as India business accelerated

Resurfacing details from Marico's Q1 FY26 results announced in early August 2025: revenue came in at Rs 3,259 crore, up 23.3% year on year, while net profit rose 8.2% to Rs 513 crore. India revenue grew 27.2% and international revenue increased 12.9%. The company also raised its fully diluted stake in Plix parent Satiya Nutraceuticals to 60%.

— FiledSat, 12 Sept, 2026, 17:34 IST·First seen Sat, 12 Sept, 2026, 17:34 IST·Source Financial Express (via Wayback)

What happened

Marico reported Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by a 27.2% rise in India revenue. It increased its Plix parent Satiya

Key facts

  • Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY from Rs 474 crore
  • Revenue from operations: Rs 3,259 crore, up 23.31% YoY from Rs 2,643 crore
  • Total income: Rs 3,315 crore
  • Other income: Rs 56 crore
  • Total expenses: Rs 2,659 crore, versus Rs 2,075 crore
  • India revenue: Rs 2,495 crore, up 27.17% YoY from Rs 1,962 crore
  • International revenue: Rs 764 crore, up 12.91% YoY from Rs 681 crore
  • India segment PBT: Rs 469 crore
  • International segment profit: Rs 213 crore
  • Stake in Satiya Nutraceuticals/Plix increased to 60% on a fully diluted basis

Why this matters

Raising its stake in Plix parent Satiya Nutraceuticals to 60% gives Marico greater control over its health-and-wellness platform and indicates continued appetite for adjacent-category expansion.

What to watch

  • India volume growth versus price-led growth in the next quarterly update.
  • Gross-margin trend and commentary on copra, edible oil, crude derivatives and packaging costs.
  • Plix revenue growth, channel expansion, profitability and evidence of integration synergies.
  • International constant-currency growth, especially in Bangladesh, MENA, South Africa and Southeast Asia.
  • Whether profit growth narrows or widens its gap with 23.3% consolidated revenue growth.
  • Accelerate Plix distribution through Marico's general trade, modern trade and e-commerce network following the stake increase to 60%.
  • Expand premium health, nutrition, personal-care and digital-first portfolios to reduce dependence on mature core categories.
  • Use India momentum to fund selective international market investment while prioritizing margin discipline.
  • Calibrate pricing and pack-size actions if commodity inflation persists, particularly in coconut-oil-linked categories.